Source
Trends in Pharmacological Sciences, 31, 2, (2010), pp. 60-65ISSN
Annotation
01 februari 2010
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Cognitive Neuroscience
Neurophysiology
Journal title
Trends in Pharmacological Sciences
Volume
vol. 31
Issue
iss. 2
Languages used
English (eng)
Page start
p. 60
Page end
p. 65
Subject
Biophysics; DCN 2: Functional Neurogenomics; DCN 3: NeuroinformaticsAbstract
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for the treatment of depression and anxiety-related disorders. These drugs target the serotonin transporter (5-HTT) and increase serotonin signalling. Although chronic SSRI administration has few reported side effects, recent observations suggest that it could have long-term effects on neurodevelopment. First, 5-HTT is transiently expressed in many brain areas during development. Second, 5-HTT blockade during development causes wiring defects in these areas. These effects are seen most clearly in the sensory systems. Third, the behavioural effects of 5-HTT blockade during development are sometimes dramatically different from the effects of 5-HTT blockade during adulthood. Most of this evidence was collected from studies with 5-HTT knockout mice and rats. However, the phenotypes associated with low or high functioning 5-HTT alleles in humans can result from similar developmental alterations in 5-HT levels. Here, we review the existing evidence on the long-term effects of developmental SSRI exposure.
This item appears in the following Collection(s)
- Academic publications [238586]
- Faculty of Medical Sciences [90409]
- Faculty of Science [34995]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.